Biote
BTMD
89 hedge funds and large institutions have $252M invested in Biote in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 10 closing their positions.
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
40% more capital inflows, than outflows
Capital inflows: $76.5M | Capital outflows: $54.5M
14% more funds holding
Funds holding: 78 → 89 (+11)
5.75% more ownership
Funds ownership: 74.56% → 80.31% (+5.7%)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Taconic Capital Advisors
New York
|
+$13.1M |
| 2 |
BlueCrest Capital Management
St Helier,
Jersey
|
+$11M |
| 3 |
Barclays
London,
United Kingdom
|
+$6.4M |
| 4 |
First Trust Capital Management
Chicago,
Illinois
|
+$5.05M |
| 5 |
Alpha Wave Global
New York
|
+$4.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Glazer Capital
New York
|
-$28.8M |
| 2 |
Bulldog Investors
Saddle Brook,
New Jersey
|
-$6.5M |
| 3 |
HIH
HRS Investment Holdings
New York
|
-$4.61M |
| 4 |
Cantor Fitzgerald Investment Advisors
New York
|
-$4.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.91M |
BTMD Hedge Fund Activity: Q1 2022 in Review
89 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Biote (BTMD) for Q1 2022, worth a combined $252M — up 10% from $228M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new BTMD positions and 10 closed out — a net gain of 11 holders — while 18 added to existing stakes and 9 trimmed.
The largest buyer was Taconic Capital Advisors, opening a new position worth an estimated $13.1M. The largest seller was Glazer Capital, exiting entirely with an estimated $28.8M sold.
- 89 institutional investors held Biote (BTMD) as of Q1 2022, up from 78 in Q4 2021.
- Funds reported $252M of Biote stock for Q1 2022, up 10% quarter-over-quarter.
- 21 funds opened new Biote positions in Q1 2022 and 10 closed out, a net change of +11 holders.
- The largest Biote buyer in Q1 2022 was Taconic Capital Advisors, an estimated $13.1M added.
- The largest Biote seller in Q1 2022 was Glazer Capital, an estimated $28.8M sold.
Based on aggregated 13F filings for Q1 2022.